Ret 80 6082 Pill: purple, round
Generic Name: selpercatinib
The pill with imprint Ret 80 6082 (Purple, Round, 0mm) has been identified as Retevmo 80 mg and is used for Non Small Cell Lung Cancer, Solid Tumors, and Thyroid Cancer. It belongs to the drug class multikinase inhibitors and is not a controlled substance.
Images for Ret 80 6082
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Ret 80 6082
- Strength
- 80 mg
- Color
- Purple (dark red-purple)
- Shape
- Round (film-coated)
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-6082
See also:
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.